Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
BIOD [NASD]
Biodel Inc.
Index- P/E- EPS (ttm)-0.60 Insider Own10.21% Shs Outstand23.46M Perf Week0.00%
Market Cap37.30M Forward P/E- EPS next Y-1.12 Insider Trans- Shs Float23.18M Perf Month16.91%
Income-12.70M PEG- EPS next Q-0.25 Inst Own25.10% Short Float3.65% Perf Quarter-19.29%
Sales- P/S- EPS this Y35.10% Inst Trans30.64% Short Ratio8.11 Perf Half Y-20.90%
Book/sh1.01 P/B1.57 EPS next Y-33.30% ROA-44.70% Target Price4.50 Perf Year-27.73%
Cash/sh1.04 P/C1.52 EPS next 5Y- ROE-55.10% 52W Range1.20 - 3.71 Perf YTD-30.26%
Dividend- P/FCF- EPS past 5Y8.60% ROI- 52W High-57.14% Beta2.06
Dividend %- Quick Ratio12.60 Sales past 5Y- Gross Margin- 52W Low32.50% ATR0.09
Employees35 Current Ratio12.60 Sales Q/Q- Oper. Margin- RSI (14)52.33 Volatility4.94% 5.68%
OptionableYes Debt/Eq0.00 EPS Q/Q77.30% Profit Margin- Rel Volume0.14 Prev Close1.57
ShortableYes LT Debt/Eq0.00 EarningsDec 16 AMC Payout- Avg Volume104.25K Price1.59
Recom1.80 SMA202.71% SMA501.57% SMA200-27.19% Volume14,100 Change1.27%
May-10-13Upgrade Ladenburg Thalmann Neutral → Buy $6
Apr-16-12Upgrade JMP Securities Mkt Perform → Mkt Outperform $3
May-26-11Initiated Global Hunter Securities Accumulate $5
Feb-04-11Reiterated Wedbush Outperform $7 → $5
Dec-10-10Reiterated Wedbush Outperform $10 → $7
Nov-02-10Reiterated Wedbush Outperform $17 → $10
Nov-02-10Downgrade Ladenburg Thalmann Buy → Neutral $14 → $2
Oct-19-10Initiated JMP Securities Mkt Perform
Mar-25-09Reiterated Wedbush Morgan Buy $10 → $16
Mar-25-09Reiterated Ladenburg Thalmann Buy $9.50 → $14
Dec-11-08Reiterated Ladenburg Thalmann Buy $11 → $9.50
Nov-20-08Reiterated Cantor Fitzgerald Buy $33 → $15
Sep-19-08Downgrade Argus Buy → Sell
Sep-11-08Initiated Oppenheimer Perform
Sep-08-08Reiterated Ladenburg Thalmann Buy $23 → $11
May-16-08Initiated Cantor Fitzgerald Buy $33
May-02-08Initiated Pacific Growth Equities Buy
Feb-27-08Initiated JP Morgan Overweight
Feb-25-08Initiated Punk, Ziegel & Co Buy $23
Jun-20-07Initiated Banc of America Sec Buy $23
Nov-18-14 04:02PM  Biodel Successfully Defends Ultra-Rapid-Acting Insulin Formulation Technology in European Patent Office Opposition Proceedings Marketwired
06:17AM  ArQule (ARQL) Shows Strength: Stock Adds 6 % in Session Zacks
06:13AM  Esperion Therapeutics (ESPR) Jumps: Stock Moves Up 6.4% Zacks
Nov-07-14 05:46AM  Endocyte, Inc. (ECYT) in Focus: Stock Surges 18% Zacks
Nov-03-14 05:47AM  Flamel Technologies (FLML) Crumbles: Stock Falls by 7.1% Zacks
Oct-30-14 07:24AM  Synergy Pharmaceuticals, Inc. (SGYP) Surges: Stock Rises 10% Zacks
Oct-27-14 09:37AM  BIODEL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
Sep-15-14 07:00AM  Biodel Announces Data Presentations at the 50th Annual Meeting of the EASD Marketwired
Aug-27-14 04:00PM  BIODEL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
Aug-25-14 04:00PM  Biodel Appoints Gary G. Gemignani as Chief Financial Officer Marketwired
Aug-22-14 01:04PM  BIODEL INC Financials EDGAR Online Financials
Aug-14-14 09:58AM  Biodel Q3 Loss Narrower than Expected, Gives Pipeline Update Zacks
Aug-13-14 05:01PM  BIODEL INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Aug-11-14 05:02PM  [video] Stocks Close Higher, But Off Day's Highs at TheStreet
04:30PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
04:05PM  Biodel Reports Third Quarter Fiscal Year 2014 Financial Results Marketwired
07:30AM  Biodel's insulin drug found effective in trial Reuters
07:07AM  Q3 2014 BIODEL INC Earnings Release - 4:00 pm ET CCBN
07:00AM  Biodel's Concentrated Insulin BIOD-531 Demonstrates Superior Glucose Control Following Standardized Meals Compared to Marketed Insulins in a Phase 2 Clinical Trial in Patients With Type 2 Diabetes Marketwired
Aug-06-14 07:00AM  Biodel to Present at the Wedbush PacGrow Life Sciences Management Access Conference Marketwired
Aug-05-14 07:00AM  Biodel to Report Third Quarter Fiscal Year 2014 Financial Results on August 11, 2014 Marketwired
Jul-28-14 06:00AM  Biodel Enters Into $15 Million Equity Commitment With Lincoln Park Capital Marketwired
Jun-11-14 07:30AM  Biodel to Present at the JMP Securities Healthcare Conference Marketwired
Jun-10-14 07:00AM  Biodel to Present Data on Ultra-Rapid-Acting Insulin and Glucagon Product Candidates at 2014 American Diabetes Association Scientific Sessions Marketwired +5.41%
May-23-14 04:02PM  BIODEL INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
May-16-14 09:20AM  Biodel Q2 Loss Wider Than Expected Zacks
May-14-14 05:18PM  BIODEL INC Files SEC form 10-Q, Quarterly Report EDGAR Online
May-13-14 08:44PM  Biodel's (BIOD) CEO Dr. Errol De Souza on Q2 2014 Results - Earnings Call Transcript at Seeking Alpha
04:46PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
04:03PM  Biodel reports Q2 EPS (29c), consensus (24c) at theflyonthewall.com
04:00PM  Biodel Reports Second Quarter Fiscal Year 2014 Financial Results GlobeNewswire
07:07AM  Q2 2014 BIODEL INC Earnings Release - 4:00 pm ET CCBN
May-07-14 04:00PM  Biodel to Report Second Quarter Fiscal Year 2014 Financial Results on May 13, 2014 GlobeNewswire -5.33%
Apr-24-14 04:30PM  Biodel, HEC Pharm Ink Deal Zacks
Apr-22-14 04:02PM  Biodel announces insulin collaboration pact with HEC Pharm at theflyonthewall.com
04:00PM  Biodel Announces Collaboration Agreement With HEC Pharm for Development of Ultra-Rapid-Acting Insulin Aspart Formulation GlobeNewswire
Apr-16-14 12:30PM  Abbott Labs Tops Earnings, Misses Sales Est Zacks
Mar-10-14 04:06PM  BIODEL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Mar-05-14 07:04PM  On The Fly: After Hours Movers at theflyonthewall.com
04:00PM  Biodel Announces Commercial Manufacturing Agreement With Emergent BioSolutions for Glucagon Rescue Product GlobeNewswire
Mar-04-14 07:00AM  Biodel to Present at the 26th Annual ROTH Conference GlobeNewswire
Feb-13-14 04:40PM  Positive Phase I Data from Biodel Zacks
Feb-12-14 04:30PM  Biodel Announces Plans to Advance BIOD-531 Based on Positive Clinical Trial Results GlobeNewswire
Feb-10-14 04:33PM  BIODEL INC Files SEC form 10-Q, Quarterly Report EDGAR Online +8.66%
01:49PM  Biodel Q1 Loss Narrows Zacks
Feb-07-14 11:33PM  Biodel's CEO Discusses F1Q 2014 Results - Earnings Call Transcript at Seeking Alpha
08:15AM  Eight Biotech Stocks Trading Near $5 With Huge Upside Potential at 24/7 Wall St.
Feb-06-14 04:51PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:03PM  Biodel Reports First Quarter Fiscal Year 2014 Financial Results GlobeNewswire
11:40AM  Avanir Reports Narrower Loss, Revs Up Y/Y Zacks
07:07AM  Q1 2014 BIODEL INC Earnings Release - 4:00 pm ET CCBN
Feb-05-14 04:00PM  Biodel to Report First Quarter Fiscal Year 2014 Financial Results on February 6, 2014 GlobeNewswire
Feb-04-14 04:15PM  Biodel to Present at Upcoming Conferences GlobeNewswire
Jan-08-14 09:28AM  Some Stock Ideas For January 2014 at Seeking Alpha
Jan-02-14 01:11PM  5 Stocks Under $10 Set to Soar at TheStreet +21.49%
10:00AM  Biodel Inc: Strong Biotech 'January Effect' Candidate For 2014 at Seeking Alpha
Dec-27-13 11:03AM  Biodel Offers Opportunity in the Growing Insulin, Glucagon Markets TheStreet
11:03AM  Biodel Offers Opportunity in the Growing Insulin, Glucagon Markets at TheStreet
Dec-20-13 04:03PM  BIODEL INC Files SEC form 10-K, Annual Report EDGAR Online
Dec-19-13 06:03PM  Nasdaq stocks posting largest volume increases AP
Dec-18-13 09:16PM  Biodel's CEO Discusses F4Q 2013 Results - Earnings Call Transcript at Seeking Alpha -5.19%
04:30PM  Biodel Reports Fourth Quarter Fiscal Year 2013 Financial Results GlobeNewswire
04:06PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
07:07AM  Q4 2013 BIODEL INC Earnings Release - 4:30 pm ET CCBN
Dec-17-13 08:17AM  Biodel Announces Commercial Supply Agreement With BD for Liquid Glucagon Rescue Device GlobeNewswire
Dec-12-13 07:00AM  Biodel to Report Fourth Quarter Fiscal Year 2013 Financial Results on December 18, 2013 GlobeNewswire
Nov-07-13 04:00PM  InPlay: Biodel advances ultra-rapid-acting concentrated insulin formulation into clinical development Briefing.com
04:00PM  Biodel Advances Ultra-Rapid-Acting Concentrated Insulin Formulation Into Clinical Development GlobeNewswire
Sep-24-13 09:55AM  Biodel CEO Buys 10K Shares and 4 Insider Buys to Note at Wall St. Cheat Sheet
Sep-19-13 04:40PM  Is Biodel A Buy Or Sell? at Seeking Alpha
Sep-12-13 10:55AM  Biodel: Creating A Better, Faster Acting Insulin, The Next Big Thing For Diabetic Therapy at Seeking Alpha
Sep-10-13 05:30PM  Data on Biodel's BIOD-123 Zacks
Sep-09-13 02:08PM  Biodel's CEO Presents at Study 3-201Top Line Data Conference Call (Transcript) at Seeking Alpha -29.82%
12:15PM  Five Highly Unusual Hot Stocks on the Move for Monday 24/7 Wall St.
10:14AM  Biodel Fails to Excite Investors With Me-Too Mealtime Insulin at TheStreet
07:46AM  BIODEL INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Biodel Inc., a specialty biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes in the United States. It is involved in developing proprietary insulin formulations for type 1 and type 2 diabetes patients; ultra-rapid-acting insulin analog-based formulations; glucagon formulations and presentations for use as a rescue treatment for diabetes patients experiencing severe hypoglycemia or very low concentrations of blood glucose; and other recombinant human insulin-based formulations. The company was founded in 2003 and is headquartered in Danbury, Connecticut.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pereira Brian JGDirectorDec 20Sale2.264,73410,6990Dec 23 07:21 PM